Clinical Trial Update: Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is recruiting to evaluate a combination therapy for localized pancreatic ductal adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Gulam Manji | Conditions: Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: RECRUITING